Mingqun Lin
Immunology and Microbiology · The Ohio State University
Publications
66
Citations
2,790
Est. group size
~8
Recurring co-author estimate
Active years
30
Publishing since 1997
Mingqun Lin's research falls under immunology and microbiology, with work touching on vector-borne and mosquito-borne diseases, bacterial toxin mechanisms, antimicrobial peptides, and antiviral drug development. Recent publications include studies on bacterial pathogenesis linked to amyloid proteins and the design of chemical compounds as potential treatments for hepatitis B virus (HBV). The available topic data does not clearly indicate a single dominant specialty, suggesting a research portfolio spanning infectious disease mechanisms and therapeutic compound development.
Publication output has been variable but generally steady to slightly increasing over the last decade, with recent years (2023-2026) showing higher activity than earlier years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Pathogenesis of Klebsiella Pneumoniae Induced Proteinopathy is Amyloid Strain Dependent
American Journal of Clinical Pathology · 2024
- Advanced generation of paeonol-phenylsufonyl derivatives as potential anti-HBV agents
RSC Advances · 2016
- mBio×9
- Proceedings of the National Academy of Sciences×5
- Figshare×3
- Frontiers in Cellular and Infection Microbiology×2
- Autophagy×1
- Yasuko Rikihisa
Immunology and Microbiology · The Ohio State University
- Nan Duan
Immunology and Microbiology · The Ohio State University
- Wenqing Zhang
Immunology and Microbiology · The Ohio State University
- Oghenekaro Omodior
Immunology and Microbiology · Indiana University
- Paula Lado
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile